Cargando…
Identification of lung cancer with high sensitivity and specificity by blood testing
BACKGROUND: Lung cancer is a very frequent and lethal tumor with an identifiable risk population. Cytological analysis and chest X-ray failed to reduce mortality, and CT screenings are still controversially discussed. Recent studies provided first evidence for the potential usefulness of autoantigen...
Autores principales: | Leidinger, Petra, Keller, Andreas, Heisel, Sabrina, Ludwig, Nicole, Rheinheimer, Stefanie, Klein, Veronika, Andres, Claudia, Staratschek-Jox, Andrea, Wolf, Jürgen, Stoelben, Erich, Stephan, Bernhard, Stehle, Ingo, Hamacher, Jürg, Huwer, Hanno, Lenhof, Hans-Peter, Meese, Eckart |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2832627/ https://www.ncbi.nlm.nih.gov/pubmed/20146812 http://dx.doi.org/10.1186/1465-9921-11-18 |
Ejemplares similares
-
Novel autoantigens immunogenic in COPD patients
por: Leidinger, Petra, et al.
Publicado: (2009) -
Longitudinal study on circulating miRNAs in patients after lung cancer resection
por: Leidinger, Petra, et al.
Publicado: (2015) -
What makes a blood cell based miRNA expression pattern disease specific? - A miRNome analysis of blood cell subsets in lung cancer patients and healthy controls
por: Leidinger, Petra, et al.
Publicado: (2014) -
Paired proteomics, transcriptomics and miRNomics in non-small cell lung cancers: known and novel signaling cascades
por: Backes, Christina, et al.
Publicado: (2016) -
miRNAs in lung cancer - Studying complex fingerprints in patient's blood cells by microarray experiments
por: Keller, Andreas, et al.
Publicado: (2009)